Acute seizures in the acute ischemic stroke setting A step forward in their description Although the incidence of acute seizures after ischemic strokes is small, about 1.2%-4.2%, 1,2 they still represent a substantial clinical challenge. There are no clear management guidelines, and the effect on stroke outcome is a matter of debate. 3 Moreover, experiencing a seizure at stroke onset may represent a relative contraindication for thrombolysis. 4 Despite all of these clinical pitfalls and multiple published studies, there remains a lack of knowledge regarding acute seizures after acute ischemic strokes. In this issue of Neurology ® , Huang et al. 5 add information to this field.
The investigators used a large multicenter cohort of ischemic stroke patients in which stroke and seizure characteristics were prospectively collected. The strengths of this study are many: a large number of patients; welldefined variables; and a comprehensive assessment of strokes, seizures, laboratory investigations, and medical complications. Moreover, the investigators focused on only one stroke type and only on acute seizures, restricting this study to a single homogenous pathophysiologic condition, as compared to previous reports that have included ischemic and hemorrhagic stroke 1 or acute and delayed poststroke seizures. 6 The original aim of this article was to analyze acute seizures in 2 different groups: patients with seizures at stroke presentation (SSP) (within the 24 first hours after stroke) and patients with seizures during the hospital stay (SDH). This idea was based on the hypothesis that the pathophysiology in seizure generation differed depending on the stage of the stroke.
Using 10,261 ischemic stroke cases, the investigators found an incidence of 1.53% of SSP and 2.03% of SDH, similar to rates previously reported.
1,2 There were some similarities between these 2 groups. Patients with SSP or SDH have more severe strokes and needed more frequent utilization of intensive care unit facilities than patients without seizures. Moreover, patients with seizures have a higher morbidity and mortality than patients without seizures. The mortality rate at 1 month was 30.3% for patients with SDH vs 13.3% for patients without seizures and 47.6% vs 24.1% at 1 year. This association remains after correction for age, comorbidities, and stroke severity, with an odds ratio (OR) of 2.84. Of note, this is particularly true for patients with mild and moderate strokes, reflecting a possible ceiling effect on morbidity and mortality from severe strokes.
There were interesting differences between patients with SSP and SDH. SSP were more common in female patients, less common in those with motor deficits, and, perhaps surprisingly, fewer patients with SSP needed interventions, including laboratory studies, thrombolysis, and occupational therapy, than patients without SSP. The authors explain this by the fact that patients with SSP had more severe strokes for which acute thrombolysis and active rehabilitation were not indicated. SDH were associated with some important medical complications: pneumonia, urinary tract infection, and decubitus ulcer. This may suggest a probable role of an exogenous infectious process acting as a provocative factor for seizures in patients with an acute brain lesion and may represent a target for acute seizure prevention. As expected, SDH were associated with SSP. Indeed, after a multivariate analysis, SSP provide an OR of 15.1 for SDH occurrence. Another important aspect of this study is the higher rate of depression found in patients with SDH as compared to patients without seizures.
This study provides important information for clinical practice. It confirms the relatively low incidence of acute seizures in this setting. However, because stroke is by far the most frequent neurologic emergency, neurologists working in acute hospitals will still encounter acute seizures relatively frequently. Therefore, practitioners should be aware of the risk factors for acute seizures. Some of them, such as stroke severity and cortical involvement, were already known 7 and are confirmed in this study. By bringing to light some different features associated with SSP, or hyperacute seizure (younger age, female sex, absence of weakness), as compared to SDH, this study provides clinically useful information to clinicians to help them recognize patients at risk for seizures in relation to the timing of the stroke. Also, the association of SDH with infectious processes such as pneumonia, urinary tract infection, and decubitus ulcer, but also with depression, should remind clinicians to be aware of the possible risk factors and consequences of acute seizures in this setting.
The increase in morbidity and mortality after strokes, as observed in this study, is a matter of debate.
Indeed, there are conflicting data regarding the association of acute seizure and mortality. [6] [7] [8] However, because of the very large number of patients, this study provides strong support for the belief that acute seizures are associated with an increase in mortality in stroke patients. It is possible that a subgroup of patients may experience greater morbidity from acute seizures, like patients with mild or moderate stroke as found in the present study, and therefore should be carefully screened for seizure occurrence.
Some questions regarding the management of acute seizures remain without satisfactory answers. Should acute phase seizures systematically be treated? Because of the strong risk of SDH if a SSP occurred and the association between seizures and poorer outcome, secondary prevention with an antiepileptic drug (AED), as is routinely performed for acute symptomatic seizures, 9 seems to be reasonable in the setting of acute ischemic strokes. However, questions such as "How long should the treatment last?" and "Which drug should be used?" remain unsolved. Of note, none of these studies supports use of prophylactic AED administration, as stated in the current guidelines. 4, 10 Even if this study provides a step forward in the description and understanding of acute symptomatic seizures from acute ischemic stroke, prospective randomized trials assessing the place and value of AEDs and seizure control after an ischemic stroke are needed more than ever.
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